|
| Status |
Public on Feb 28, 2017 |
| Title |
EZH2 is a potential therapeutic target for H3K27M mutant paediatric gliomas |
| Organisms |
Homo sapiens; Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
28263309 |
| Submission date |
Aug 09, 2016 |
| Last update date |
May 15, 2019 |
| Contact name |
Faizaan Mohammad |
| E-mail(s) |
faizaan.mohammad@bric.ku.dk
|
| Organization name |
BRIC
|
| Street address |
Ole Maaloøs vej 5 Fourth Floor
|
| City |
Copenhagen |
| State/province |
Choose A State |
| ZIP/Postal code |
2200 |
| Country |
Denmark |
| |
|
| Platforms (2) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
| GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
|
| Samples (38)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE85385 |
EZH2 is a potential therapeutic target for H3K27M mutant paediatric gliomas [RNA-Seq - mouse cell lines] |
| GSE85386 |
EZH2 is a potential therapeutic target for H3K27M mutant paediatric gliomas [ChIP-Seq mouse cell lines] |
| GSE85387 |
EZH2 is a potential therapeutic target for H3K27M mutant paediatric gliomas [ChIP-Seq human cell lines] |
| GSE85388 |
EZH2 is a potential therapeutic target for H3K27M mutant paediatric gliomas [RNA-Seq mouse tumors] |
|
| Relations |
| BioProject |
PRJNA338311 |
Less...
More...